LoginGet started
Picture of Anygen Co logo

196300 — Anygen Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Anygen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6,645-2,462-1,690-6,205-9,079
Depreciation
Amortisation
Non-Cash Items2,9464231,3633,6955,223
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital915-370-1,423-2,982-2,394
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-737-48.3916-2,547-3,382
Capital Expenditures-3,355-959-2,090-2,425-655
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3,407-3471,4544,6991,135
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities51.9-1,306-6362,274480
Financing Cash Flow Items4006.170——
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-30.31,683-130-4813,434
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-716322148-759533